New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 28.5mg equivalent to atomoxetine 25 mg - capsule - 25 mg - active: atomoxetine hydrochloride 28.5mg equivalent to atomoxetine 25 mg excipient: gelatin   indigo carmine iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 28.575mg equivalent to atomoxetine 25mg - capsule - 25 mg - active: atomoxetine hydrochloride 28.575mg equivalent to atomoxetine 25mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 20.5mg equivalent to atomoxetine 18 mg - capsule - 18 mg - active: atomoxetine hydrochloride 20.5mg equivalent to atomoxetine 18 mg excipient: gelatin   iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 45.5mg equivalent to atomoxetine 40 mg - capsule - 40 mg - active: atomoxetine hydrochloride 45.5mg equivalent to atomoxetine 40 mg excipient: gelatin   indigo carmine   iron oxide yellow   starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 11.4mg equivalent to atomoxetine 10 mg - capsule - 10 mg - active: atomoxetine hydrochloride 11.4mg equivalent to atomoxetine 10 mg excipient: gelatin   starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 68.3mg equivalent to atomoxetine 60 mg - capsule - 60 mg - active: atomoxetine hydrochloride 68.3mg equivalent to atomoxetine 60 mg excipient: gelatin   indigo carmine iron oxide yellow   starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 91.2mg equivalent to atomoxetine 80 mg - capsule - 80 mg - active: atomoxetine hydrochloride 91.2mg equivalent to atomoxetine 80 mg excipient: gelatin   iron oxide red iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 5.715mg equivalent to atomoxetine 5mg - capsule - 5 mg - active: atomoxetine hydrochloride 5.715mg equivalent to atomoxetine 5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide yellow   magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - atomoxetine hydrochloride, quantity: 28.5 mg (equivalent: atomoxetine, qty 25 mg) - capsule, hard - excipient ingredients: iron oxide yellow; gelatin; titanium dioxide; pregelatinised maize starch; indigo carmine; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for the treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 11.43mg equivalent to atomoxetine 10mg - capsule - 10 mg - active: atomoxetine hydrochloride 11.43mg equivalent to atomoxetine 10mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.